- Eligible applicants must hold an MD, MD/PhD, PhD, DO, MBBS, or an equivalent medical degree.
- Only applicants and mentors employed by academic, non-commercial institutions are eligible. Applicants must declare their intent to pursue an academic research career in hemostasis or thrombosis (or an academic research career that will have a substantial component of, or overlap with, hemostasis and/or thrombosis).
- U.S. or Canadian citizenship is not required to apply; however, award recipients must agree to live and work in the U.S. or Canada for the tenure of their MRA-funded project. Non-U.S. citizen applicants with a J1 Visa waiver – even those in their first faculty positions – are encouraged to apply, as are those with an equivalent Canadian visa.
HTRS encourages applicants from historically excluded and underrepresented populations to apply, understanding that a diverse scientific workforce will, according to NIH research: foster scientific innovation, contribute to robust learning environments, improve the quality of the research, and advance the likelihood that underserved or health-disparate populations will benefit from this research.
This includes individuals from racial and ethnic groups who have been shown by the National Science Foundation to be underrepresented and/or historically excluded in health-related sciences on a national basis, as well as individuals with disabilities, students from low socioeconomic (SES) status backgrounds, individuals from disadvantaged backgrounds, and women.
MRAs of $162,000 USD will be distributed by HTRS to the successful applicant’s institution in three payments: 1. The first payment of $81,000 USD (50% of the award) will be issued after full execution of the legal grant agreement contract between HTRS, the awardee, and the recipient institution. 2. The second payment of $64,800 USD (40% of the award) will be issued after HTRS approves a formal 12- month progress report describing research conducted during the first year of the project period. 3. The third payment of $16,200 USD (10% of the award) is contingent upon approval by HTRS of a final, 24-month report upon completion of the project period.